Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $350
Portfolio Pulse from richadhand@benzinga.com
Stifel analyst Jonathan Block has maintained a 'Buy' rating on Inspire Medical Systems (NYSE:INSP) and raised the price target from $300 to $350.
July 13, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inspire Medical Systems' price target has been raised from $300 to $350 by Stifel, maintaining a 'Buy' rating.
The raised price target indicates that the analyst sees potential for the stock's price to increase. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100